@xconomy.com 3 years ago
Praxis Precision Medicines Leads Way as Three More Biotechs Prep IPOs
@xconomy.com 3 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com 4 years ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More
@xconomy.com 5 years ago
Former Zavante Executive Tapped as Abide Therapeutics President
@Primary_Immune 5 years ago
The Remarkable Story Behind the Story of the First FDA Approved #Marijuana-Based Drug (For Rare #Epilepsy) | https://www.cincinnati.com/story/news/2018/06/27/cincinnati-test-site-weed-drug-fda-has-just-approved/732043002/ #MedED #ITRTG #BigData #science #technology #genetics #SNRTG #biotech #Dravet #MedicalMarijuana #inspiration #RareDisease #SciComm By @apsaker https://t.co/eNC61FgOhS
@Primary_Immune 5 years ago
The First #Cannabis-Based Drug (For #Epilepsy) Just Gained FDA Approval; The Remarkable Story Behind the Story https://www.cincinnati.com/story/news/2018/06/27/cincinnati-test-site-weed-drug-fda-has-just-approved/732043002/ #ITRTG #BigData #science #technology #genetics #SNRTG #biotech #Dravet #marijuana #MedicalMarijuana #inspiration #RareDisease #SciComm @apsaker https://t.co/QcweE89RhI